Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pablo Gonzalez-Navarro
Observed names:
P. González Navarro,
Pablo González Navarro
Institution:
Instituto de Investigación Sanitaria Gregorio Marañón
Observed institution:
Instituto de Investigación Sanitaria Gregorio Marañón
ORCID:
0000-0002-6906-6556
Observed ORCID:
0000-0002-6906-6556
OpenAlex ID:
A5107786031
Efficacy, safety, and tolerability of arbaclofen in Autistic children and adolescents, the AIMS-2-TRIALS-CT1: a randomized, double-blind, placebo-controlled phase II trial
2026
·
M. Parellada
, A. San José Cáceres
, et al.
·
EClinicalMedicine
·
5
PDF
First evaluation of N170 latency as an EEG biomarker of treatment response in a randomised controlled trial of arbaclofen for autism
2026
·
Eleonora Broggi
, Teresa Del Bianco
, et al.
·
Molecular Autism
·
1
5.65 Arbaclofen Trial for Youth With ASD: European and Canadian Trials
2024
·
Mara Parellada
, Paul P. Wang
, et al.
·
Journal of the American Academy of Child & Adolescent Psychiatry
Show more works
View as search
Works count:
3
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type